Search

Your search keyword '"METABOLOMIC fingerprinting"' showing total 33 results
Start Over Descriptor "METABOLOMIC fingerprinting" Topic health and medicine
33 results on '"METABOLOMIC fingerprinting"'

1. Findings from Fudan University Provide New Insights into Pancreatic Cancer (Accelerated Exosomal Metabolic Profiling Enabled By Robust On-target Array Sintering With Metal-organic Frameworks).

Subjects
MEDICAL sciences, METABOLOMIC fingerprinting, PANCREATIC cancer, IN situ processing (Mining), MEDICAL screening
Abstract

A recent study conducted by Fudan University in Shanghai, China, has developed a new method for the early detection and diagnosis of pancreatic cancer. The researchers created a high-throughput On-Target Array Extraction Platform (OTAEP) using metal-organic frameworks (MOFs) to extract exosomes and their metabolic profiles. By combining this platform with machine learning, the researchers were able to identify five biomarkers that enable early diagnosis, risk stratification, and staging of pancreatic cancer with high sensitivity and specificity. This breakthrough has the potential to improve the efficiency and accuracy of large-scale screening for pancreatic cancer. [Extracted from the article]

Published
2024

2. Studies from Detroit in the Area of Multiple Sclerosis Published (Utility of an Untargeted Metabolomics Approach Using a 2D GC-GC-MS Platform to Distinguish Relapsing and Progressive Multiple Sclerosis).

Subjects
CENTRAL nervous system diseases, NEUROLOGICAL disorders, DEMYELINATION, MULTIPLE sclerosis, METABOLOMIC fingerprinting, AUTOIMMUNE diseases
Abstract

A recent study conducted in Detroit, Michigan, explored the use of an untargeted metabolomics approach to distinguish between different types of multiple sclerosis (MS). The researchers analyzed the serum of patients with relapsing-remitting MS (RRMS), primary progressive MS (PPMS), and healthy subjects (HS) using a 2D GC-GC-MS platform. They identified several altered metabolites that were significantly different between the RRMS and HS groups, as well as between the PPMS and HS groups. Pathway analysis revealed the enrichment of specific metabolic pathways in both RRMS and PPMS. The study suggests that these altered metabolites could potentially be used to develop a metabolite panel for distinguishing MS from healthy individuals. [Extracted from the article]

Published
2024

3. Mayo Clinic Researcher Targets Ischemia (A brief harvesting-freezing delay significantly alters the kidney metabolome and leads to false positive and negative results).

Subjects
DIGESTIVE system diseases, POLYCYSTIC kidney disease, SPRAGUE Dawley rats, LABORATORY rats, METABOLOMIC fingerprinting
Abstract

A recent study conducted at the Mayo Clinic in Rochester, Minnesota, investigated the effects of a brief delay in kidney harvesting and freezing on the metabolome of the kidneys. The researchers found that this delay resulted in significant metabolic changes in both wild-type and polycystic kidney disease (PKD) kidneys. However, there were notable differences between the two genotypes, leading to false positive and negative results when comparing them. The study suggests that a quick clamp-freezing technique for kidney metabolomics provides a more accurate interpretation of the metabolic changes associated with kidney disease. [Extracted from the article]

Published
2024

4. New Study Findings from Jiangsu University Illuminate Research in Veterans (Clinical validation and application value exploration of multi-modal pulmonary nodule diagnosis model).

Subjects
SPIRAL computed tomography, MEDICAL sciences, METABOLOMIC fingerprinting, MEDICAL screening, REPORTERS & reporting, PULMONARY nodules
Abstract

A study conducted by researchers at Jiangsu University in China explored the clinical application value of a multi-modal pulmonary nodule diagnosis model for veterans. The study enrolled 289 patients with pulmonary nodules and used various methods, including metabolic fingerprints, protein biomarker CEA, and image analysis, to calculate the malignant probability score of each patient. The results showed that the multi-modal diagnosis model had good diagnostic performance in differentiating between benign and malignant nodules, outperforming existing models. The researchers concluded that the multi-modal diagnosis model has potential clinical application value. [Extracted from the article]

Published
2024

5. New Kidney Cancer Study Findings Have Been Reported by Investigators at Shanghai Jiao Tong University (Engineering a Bifunctional Smart Nanoplatform Integrating Nanozyme Activity and Self-assembly for Kidney Cancer Diagnosis and Classification).

Subjects
TECHNOLOGICAL innovations, RENAL cancer, METABOLOMIC fingerprinting, LIQUID-liquid interfaces, TUMOR classification
Abstract

A recent study conducted by investigators at Shanghai Jiao Tong University in China has developed a new nanoplatform for the diagnosis and classification of kidney cancer. The researchers created a bifunctional smart nanoplatform that integrates nanozyme activity and self-assembly. This platform was able to accurately detect glucose in serum for kidney tumor diagnosis and successfully extracted metabolic fingerprints from urine samples, allowing for early-stage diagnosis, subtype classification, and discrimination of benign from malignant tumors. The researchers believe that this nanoplatform has potential for clinical disease diagnosis, point-of-care testing, and biomarker discovery. [Extracted from the article]

Published
2024

6. Researchers at Shanghai Jiao Tong University Release New Data on Carcinomas (Serum and Urine Metabolic Fingerprints Characterize Renal Cell Carcinoma for Classification, Early Diagnosis, and Prognosis).

Subjects
DESORPTION ionization mass spectrometry, RENAL cell carcinoma, METABOLOMIC fingerprinting, MEDICAL screening, BENIGN tumors
Abstract

Researchers at Shanghai Jiao Tong University have conducted a study on renal cell carcinoma (RCC), a type of kidney cancer. The researchers used a noninvasive approach called nanoparticle-enhanced laser desorption ionization mass spectrometry (NELDI MS) to analyze metabolic fingerprints of renal tumors and healthy controls. The study found that the classification models based on metabolic biomarkers were effective in distinguishing renal tumors from healthy controls, differentiating malignant from benign tumors, and classifying subtypes of RCC. The research provides promising prospects for using metabolic analytical tools for RCC characterization. [Extracted from the article]

Published
2024

7. Shanghai Jiao Tong University Researcher Reports Research in Cancer (Bile metabolic fingerprints distinguish biliary tract cancer from benign biliary diseases).

Subjects
BILIARY tract cancer, BILIOUS diseases & biliousness, METABOLOMIC fingerprinting, RESEARCH personnel, GALLBLADDER cancer, CANCER research
Abstract

A recent study conducted by researchers at Shanghai Jiao Tong University in China has developed a bile metabolite-based platform called BileMet for distinguishing between malignant and benign biliary diseases. The researchers collected samples from 336 patients and performed untargeted metabolic fingerprinting using novel nanoparticle-enhanced laser desorption/ionization mass spectrometry. They identified six metabolite biomarker candidates and found that chenodeoxycholic acid glycine conjugate plays a protective role in biliary tract cancer. The BileMet assay showed improved diagnostic capabilities and could potentially reduce the economic burden by over 90%. [Extracted from the article]

Published
2024

8. New Liver Cancer Study Results from Johns Hopkins University Described (Metabolic Fingerprinting By Nuclear Magnetic Resonance of Hepatocellular Carcinoma Cells During P53 Reactivation-induced Senescence).

Subjects
MAGNETIC resonance imaging, NUCLEAR magnetic resonance, METABOLOMIC fingerprinting, LIVER cancer, HEPATOCELLULAR carcinoma
Abstract

A recent study conducted by researchers at Johns Hopkins University focused on identifying specific markers of cancer cell senescence using nuclear magnetic resonance (NMR) spectroscopy. The study utilized murine liver carcinoma cells and analyzed metabolic changes during senescence using a magnetic resonance spectroscopy (MRS)-compatible cell perfusion system. The findings revealed elevated levels of certain metabolites in senescent cells, along with a greater ability to degrade the extracellular matrix (ECM). These metabolic differences and ECM degradation have significant implications for growth and redox metabolism and may serve as potential signals for detecting senescent cancer cells in vivo. [Extracted from the article]

Published
2024

9. Findings in Biomarkers Reported from Humboldt University (Analysis of Vitamin D Metabolic Markers By Mass Spectrometry: Recent Progress Regarding the "gold Standard" Method and Integration Into Clinical Practice).

Subjects
VITAMIN D, MASS spectrometry, BIOMARKERS, TANDEM mass spectrometry, MASS spectrometers, METABOLOMIC fingerprinting
Abstract

A recent study conducted at Humboldt University in Berlin, Germany, highlights the advancements in the analysis of vitamin D metabolic markers using mass spectrometry. The researchers emphasize that liquid chromatography/tandem mass spectrometry is now considered the gold standard technique for assessing vitamin D status and measuring vitamin D metabolic fingerprints. The study discusses the improvements in sample preparation techniques, chemical derivatization reagents, and the integration of high-resolution mass spectrometers into clinical laboratories. The research concludes by summarizing the most significant recent developments in this field. This information may be useful for individuals interested in diagnostics, screening, and nutrition. [Extracted from the article]

Published
2024

10. Researcher at Aristotle University of Thessaloniki Publishes Research in Acute Lymphoblastic Leukemia (Metabolic Fingerprint in Childhood Acute Lymphoblastic Leukemia).

Subjects
LYMPHOBLASTIC leukemia, METABOLOMIC fingerprinting, ACUTE leukemia, RESEARCH personnel
Abstract

A recent study conducted at Aristotle University of Thessaloniki in Greece explores the metabolic fingerprint of acute lymphoblastic leukemia (ALL) in children. The researchers aimed to understand the role of intermediary metabolism in the disease and identify potential biomarkers and therapeutic targets. The study analyzed plasma and urinary metabolites in 34 children with ALL and compared them to a control group. The findings revealed distinct metabolic changes in patients with ALL compared to controls, as well as differences between different subtypes of ALL and at different stages of treatment. This research provides valuable insights into the metabolic dysregulation associated with pediatric ALL and may contribute to the development of new treatments and prognostic markers. [Extracted from the article]

Published
2024

11. New Chronic Obstructive Pulmonary Disease Data Have Been Reported by Researchers at Shanghai Jiao Tong University (Plasmonic Alloys Enhanced Metabolic Fingerprints for the Diagnosis of Copd and Exacerbations).

Subjects
CHRONIC obstructive pulmonary disease, METABOLOMIC fingerprinting, RESEARCH personnel, ALLOYS, DIAGNOSIS
Abstract

Researchers at Shanghai Jiao Tong University in China have developed a new method for diagnosing chronic obstructive pulmonary disease (COPD) and exacerbations using metabolic biomarkers. The researchers designed mesoporous PdPt alloys that enable the acquisition of metabolic fingerprints within seconds, requiring only a small amount of plasma. Machine learning was used to decode the metabolic profiles and achieve a precise diagnosis of COPD and distinguish between stable COPD and acute exacerbations. This new platform could complement standard clinical techniques for managing COPD. [Extracted from the article]

Published
2024

12. Characterization of Metabolomic Fingerprints in Patients With Hepatic Encephalopathy.

Subjects
METABOLOMIC fingerprinting, HEPATIC encephalopathy, DIGESTIVE system diseases
Abstract

This document provides information about a clinical trial, NCT06245473, that focuses on the metabolomic fingerprints of hepatic encephalopathy (HE) in patients with cirrhosis. HE is a condition caused by liver disease and is characterized by neurological and/or neuropsychological symptoms. The trial aims to better understand the metabolic changes associated with HE by analyzing blood samples from cirrhotic patients. The study is observational and will take place in France, with an estimated completion date of June 1, 2024. [Extracted from the article]

Published
2024

13. Research Conducted at Shanghai Jiao Tong University Has Updated Our Knowledge about Prostate Cancer (Identifying High Gleason Score Prostate Cancer By Prostate Fluid Metabolic Fingerprint-based Multi-modal Recognition).

Subjects
GLEASON grading system, PROSTATE cancer, TECHNOLOGICAL innovations, METABOLOMIC fingerprinting, BENIGN prostatic hyperplasia
Abstract

A study conducted at Shanghai Jiao Tong University in China has made advancements in our understanding of prostate cancer. Prostate cancer is the second most common cancer in males worldwide, and the Gleason scoring system is an important prognostic factor for the disease. The study utilized ferric nanoparticle-assisted laser desorption/ionization mass spectrometry to extract prostate fluid metabolic fingerprints and combined this with clinical features to establish a multi-modal diagnosis for high Gleason score prostate cancer. The approach yielded promising results, surpassing single-modal diagnosis methods. The study provides valuable insights into the metabolic pathways and pathological mechanisms underlying high Gleason score prostate cancer. [Extracted from the article]

Published
2024

14. Findings from Shanghai Jiao Tong University Advance Knowledge in Prostate Cancer (Precise diagnosis and risk stratification of prostate cancer by comprehensive serum metabolic fingerprints: A prediction model study).

Subjects
METABOLOMIC fingerprinting, PROSTATE cancer, PREDICTION models, DIAGNOSIS, MACHINE learning, MEDICAL screening
Abstract

A study conducted by researchers at Shanghai Jiao Tong University in China has developed a novel approach for the precise diagnosis and risk stratification of prostate cancer (PCa). The study utilized mass spectrometry (MS) analysis of blood samples combined with machine learning algorithms to construct diagnostic and stratification models. The diagnostic model demonstrated a remarkable accuracy of 100% in distinguishing between PCa and non-PCa patients, and the risk stratification model accurately classified subjects as low-risk or high-risk. The study provides new insights into the metabolic alterations in PCa and could aid in timely diagnosis and treatment decisions. [Extracted from the article]

Published
2024

15. Reports on Lupus Findings from Shanghai Jiao Tong University Provide New Insights (Serum Metabolic Fingerprints Characterize Systemic Lupus Erythematosus).

Subjects
METABOLOMIC fingerprinting, RHEUMATOID arthritis, SYSTEMIC lupus erythematosus, RESEARCH personnel, SENSITIVITY & specificity (Statistics)
Abstract

A recent report from Shanghai Jiao Tong University in China discusses the use of serum metabolic fingerprints (SMFs) to identify systemic lupus erythematosus (SLE) and develop biomarkers for the disease. The study used a discovery cohort of 731 individuals, including SLE patients and healthy controls, and a validation cohort of 184 individuals. The researchers found that SMFs could accurately identify SLE with high sensitivity and specificity, and they also identified a metabolic biomarker panel that distinguished SLE patients from healthy controls and rheumatoid arthritis patients. This research provides a promising approach for the precise diagnosis of SLE and further understanding of its pathogenic mechanisms. [Extracted from the article]

Published
2023

16. Researcher at Shanghai Jiao Tong University Has Published New Data on Type 2 Diabetes (Ferric particle-assisted LDI-MS platform for metabolic fingerprinting of diabetic retinopathy).

Subjects
TYPE 2 diabetes, METABOLOMIC fingerprinting, DIABETIC retinopathy, RESEARCH personnel, DIABETIC angiopathies, EYE diseases
Abstract

A study conducted by researchers at Shanghai Jiao Tong University in China has developed a new method for analyzing the metabolic fingerprints of diabetic retinopathy (DR) in individuals with type 2 diabetes. The study used a laser desorption/ionization mass spectrometry (LDI-MS) platform assisted by ferric particles to perform metabolic fingerprinting. The researchers found that the LDI-MS platform was able to accurately diagnose DR and identified specific metabolites associated with the condition. This research has the potential to improve the clinical management of DR. [Extracted from the article]

Published
2023

17. Studies from Henan University Reveal New Findings on Squamous Cell Carcinoma (Diagnosis of Esophageal Squamous Cell Carcinoma By High-performance Serum Metabolic Fingerprints: a Retrospective Study).

Subjects
SQUAMOUS cell carcinoma, METABOLOMIC fingerprinting, ESOPHAGEAL cancer, DIAGNOSIS, RETROSPECTIVE studies
Abstract

A study conducted by researchers at Henan University in Anyang, China, has revealed new findings on the diagnosis of esophageal squamous cell carcinoma (ESCC). The researchers used ferric-particle-enhanced laser desorption/ionization mass spectrometry (FPELDI MS) to analyze serum metabolic fingerprints (SMFs) in a cohort of non-ESCC participants and ESCC patients. The diagnostic models built using SMFs achieved desirable diagnostic performance, with area-under-the-curves (AUCs) of 0.925-0.966. The study highlights the potential of metabolic analysis for accurate screening and early detection of ESCC and provides insights into the metabolic characterization of diseases. [Extracted from the article]

Published
2023

18. University of Texas Researcher Updates Current Data on Fibromyalgia (Metabolic Fingerprinting for the Diagnosis of Clinically Similar Long COVID and Fibromyalgia Using a Portable FT-MIR Spectroscopic Combined with Chemometrics).

Subjects
POST-acute COVID-19 syndrome, METABOLOMIC fingerprinting, FIBROMYALGIA, DIAGNOSIS, RESEARCH personnel, CHEMOMETRICS
Abstract

Chemometric, Clinical Medicine, Diagnostics and Screening, Emerging Technologies, Fibromyalgia, Health and Medicine, Machine Learning, Muscular Diseases and Conditions, Musculoskeletal Diseases and Conditions, Neuromuscular Diseases and Conditions, Rheumatic Diseases and Conditions Keywords: Chemometric; Clinical Medicine; Diagnostics and Screening; Emerging Technologies; Fibromyalgia; Health and Medicine; Machine Learning; Muscular Diseases and Conditions; Musculoskeletal Diseases and Conditions; Neuromuscular Diseases and Conditions; Rheumatic Diseases and Conditions EN Chemometric Clinical Medicine Diagnostics and Screening Emerging Technologies Fibromyalgia Health and Medicine Machine Learning Muscular Diseases and Conditions Musculoskeletal Diseases and Conditions Neuromuscular Diseases and Conditions Rheumatic Diseases and Conditions 589 589 1 10/24/23 20231023 NES 231023 2023 OCT 28 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Letter on the CDC & FDA -- Investigators discuss new findings in fibromyalgia. [Extracted from the article]

Published
2023

19. University of California Researcher Updates Knowledge of Metabolite Research (The Urinary Metabolomic Fingerprint in Extremely Preterm Infants on Total Parenteral Nutrition vs. Enteral Feeds).

Subjects
PARENTERAL feeding, METABOLOMIC fingerprinting, PREMATURE infants, ENTERAL feeding
Abstract

Diet and Nutrition, Feeding Methods, Health and Medicine, Life Sciences, Metabolite Research, Nutrition Therapy, Nutritional Support, Parenteral Nutrition, Total Parenteral Nutrition, Vitamins Keywords: Diet and Nutrition; Feeding Methods; Health and Medicine; Life Sciences; Metabolite Research; Nutrition Therapy; Nutritional Support; Parenteral Nutrition; Total Parenteral Nutrition; Vitamins EN Diet and Nutrition Feeding Methods Health and Medicine Life Sciences Metabolite Research Nutrition Therapy Nutritional Support Parenteral Nutrition Total Parenteral Nutrition Vitamins 7978 7978 1 09/11/23 20230915 NES 230915 2023 SEP 15 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- A new study on metabolite research is now available. University of California Researcher Updates Knowledge of Metabolite Research (The Urinary Metabolomic Fingerprint in Extremely Preterm Infants on Total Parenteral Nutrition vs. [Extracted from the article]

Published
2023

20. New Findings from University of Porto in the Area of Breast Cancer Described (The Influence of Adipocyte Secretome on Selected Metabolic Fingerprints of Breast Cancer Cell Lines Representing the Four Major Breast Cancer Subtypes).

Subjects
METABOLOMIC fingerprinting, BREAST cancer, CELL lines, CANCER cells, FAT cells
Abstract

Adipocytes, Breast Cancer, Cancer, Cell Line, Connective Tissue Cells, Health and Medicine, Oncology, Women's Health Keywords: Adipocytes; Breast Cancer; Cancer; Cell Line; Connective Tissue Cells; Health and Medicine; Oncology; Women's Health EN Adipocytes Breast Cancer Cancer Cell Line Connective Tissue Cells Health and Medicine Oncology Women's Health 736 736 1 09/11/23 20230912 NES 230912 2023 SEP 12 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Investigators publish new report on breast cancer. [Extracted from the article]

Published
2023

21. Study Findings on Biomarkers Are Outlined in Reports from University of Rosario (Metabolic fingerprinting of systemic sclerosis: a systematic review).

Subjects
METABOLOMIC fingerprinting, SYSTEMIC scleroderma, BIOMARKERS, INTERSTITIAL lung diseases, KREBS cycle, PULMONARY arterial hypertension
Abstract

The diffuse cutaneous systemic sclerosis (dcSSc) subtype showed upregulated amino acid-related pathways involved in fibrosis, endothelial dysfunction, and gut dysbiosis. Keywords: Biomarkers; Diagnostics and Screening; Health and Medicine; Risk and Prevention EN Biomarkers Diagnostics and Screening Health and Medicine Risk and Prevention 1559 1559 1 08/21/23 20230825 NES 230825 2023 AUG 25 (NewsRx) -- By a News Reporter-Staff News Editor at Genomics & Genetics Weekly -- New research on biomarkers is the subject of a new report. Lastly, potential biomarkers were evaluated for the diagnosis of SSc, the identification of the dcSSc subtype, pulmonary arterial hypertension, and interstitial lung disease. [Extracted from the article]

Published
2023

22. Researcher at University of Belgrade Has Published New Study Findings on Biomarkers (Metabolic Fingerprints of Effective Fluoxetine Treatment in the Prefrontal Cortex of Chronically Socially Isolated Rats: Marker Candidates and Predictive...).

Subjects
METABOLOMIC fingerprinting, PREFRONTAL cortex, FLUOXETINE, SEROTONIN uptake inhibitors, BIOMARKERS
Abstract

Antidepressants, Biomarkers, Brain Research, Central Nervous System, Cerebrum, Diagnostics and Screening, Drugs and Therapies, Fluoxetine Therapy, Frontal Lobe, Health and Medicine, Machine Learning, Pharmaceuticals, Prefrontal Cortex, Propylamines, Prosencephalon, Psychotherapeutic Agents, Risk and Prevention, Selective Serotonin Reuptake Inhibitors, Support Vector Machines, Telencephalon Keywords: Antidepressants; Biomarkers; Brain Research; Central Nervous System; Cerebrum; Diagnostics and Screening; Drugs and Therapies; Fluoxetine Therapy; Frontal Lobe; Health and Medicine; Machine Learning; Pharmaceuticals; Prefrontal Cortex; Propylamines; Prosencephalon; Psychotherapeutic Agents; Risk and Prevention; Selective Serotonin Reuptake Inhibitors; Support Vector Machines; Telencephalon EN Antidepressants Biomarkers Brain Research Central Nervous System Cerebrum Diagnostics and Screening Drugs and Therapies Fluoxetine Therapy Frontal Lobe Health and Medicine Machine Learning Pharmaceuticals Prefrontal Cortex Propylamines Prosencephalon Psychotherapeutic Agents Risk and Prevention Selective Serotonin Reuptake Inhibitors Support Vector Machines Telencephalon 1948 1948 1 07/17/23 20230721 NES 230721 2023 JUL 21 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- Current study results on biomarkers have been published. [Extracted from the article]

Published
2023

23. Institut Universitaire de la Face et du Cou Researcher Updates Understanding of Thyroid Nodules (Pilot Study on the Use of Untargeted Metabolomic Fingerprinting of Liquid-Cytology Fluids as a Diagnostic Tool of Malignancy for Thyroid Nodules).

Subjects
METABOLOMIC fingerprinting, THYROID nodules, PILOT projects
Abstract

Keywords: Cytology; Diagnostics and Screening; Endocrine Gland Neoplasms; Health and Medicine; Thyroid Diseases and Conditions; Thyroid Neoplasms; Thyroid Nodules EN Cytology Diagnostics and Screening Endocrine Gland Neoplasms Health and Medicine Thyroid Diseases and Conditions Thyroid Neoplasms Thyroid Nodules 2352 2352 1 07/10/23 20230714 NES 230714 2023 JUL 14 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- New research on thyroid nodules is the subject of a new report. Keywords for this news article include: Institut Universitaire de la Face et du Cou, Nice, France, Europe, Cytology, Thyroid Nodules, Thyroid Neoplasms, Health and Medicine, Diagnostics and Screening, Endocrine Gland Neoplasms, Thyroid Diseases and Conditions. Cytology, Diagnostics and Screening, Endocrine Gland Neoplasms, Health and Medicine, Thyroid Diseases and Conditions, Thyroid Neoplasms, Thyroid Nodules. [Extracted from the article]

Published
2023

24. Reports from Shanghai Jiao Tong University Provide New Insights into Women's Health (Efficient Metabolic Fingerprinting of Follicular Fluid Encodes Ovarian Reserve and Fertility).

Subjects
OVARIAN reserve, METABOLOMIC fingerprinting, WOMEN'S health, FERTILITY
Abstract

Keywords: Shanghai; People's Republic of China; Asia; Gynecology; Health and Medicine; Women's Health EN Shanghai People's Republic of China Asia Gynecology Health and Medicine Women's Health 338 338 1 07/10/23 20230711 NES 230711 2023 JUL 13 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Investigators discuss new findings in Women's Health. According to news reporting originating from Shanghai, People's Republic of China, by NewsRx correspondents, research stated, "Ovarian reserve (OR) and fertility are critical in women's healthcare. [Extracted from the article]

Published
2023

25. Researcher at University of Cagliari Details Research in Metabolite Research (Right Ventricular Subclinical Dysfunction in SLE Patients Correlates with Metabolomic Fingerprint and Organ Damage).

Subjects
RIGHT ventricular dysfunction, METABOLOMIC fingerprinting
Abstract

Keywords: Cardiology; Health and Medicine; Life Sciences; Metabolite Research EN Cardiology Health and Medicine Life Sciences Metabolite Research 616 616 1 07/10/23 20230710 NES 230710 2023 JUL 10 (NewsRx) -- By a News Reporter-Staff News Editor at Cardiovascular Week -- Current study results on metabolite research have been published. Keywords for this news article include: University of Cagliari, Monserrato, Italy, Europe, Cardiology, Life Sciences, Health and Medicine, Metabolite Research. [Extracted from the article]

Published
2023

26. Data from University of Melbourne Advance Knowledge in Antioxidants (Comprehensive Metabolite Fingerprinting of Australian Black and Green Olives and Their Antioxidant and Pharmacokinetics Properties).

Subjects
METABOLOMIC fingerprinting, PHARMACOKINETICS, OLIVE, ANTIOXIDANTS, LIQUID chromatography-mass spectrometry
Abstract

Antioxidants, Drugs and Therapies, Health and Medicine, Pharmacokinetics, Pharmacology, Protective Agents Keywords: Antioxidants; Drugs and Therapies; Health and Medicine; Pharmacokinetics; Pharmacology; Protective Agents EN Antioxidants Drugs and Therapies Health and Medicine Pharmacokinetics Pharmacology Protective Agents 326 326 1 07/03/23 20230707 NES 230707 2023 JUL 7 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- Researchers detail new data in antioxidants. [Extracted from the article]

Published
2023

28. New Brain Cancer Findings from Nicolaus Copernicus University in Torun Outlined (Insight Into New Opportunities In Intra-surgical Diagnostics of Brain Tumors).

Subjects
BRAIN cancer, BRAIN tumors, METABOLOMIC fingerprinting, MEDICAL screening, ANALYTICAL chemistry
Abstract

Bydgoszcz, Poland, Europe, Brain Cancer, Cancer, Diagnostics and Screening, Health and Medicine, Oncology Keywords: Bydgoszcz; Poland; Europe; Brain Cancer; Cancer; Diagnostics and Screening; Health and Medicine; Oncology EN Bydgoszcz Poland Europe Brain Cancer Cancer Diagnostics and Screening Health and Medicine Oncology 591 591 1 06/12/23 20230613 NES 230613 2023 JUN 12 (NewsRx) -- By a News Reporter-Staff News Editor at Clinical Oncology Week -- Investigators discuss new findings in Oncology - Brain Cancer. [Extracted from the article]

Published
2023

29. Findings in Liver Cancer Reported from Nanjing University (Machine Learning-empowered Cis-diol Metabolic Fingerprinting Enables Precise Diagnosis of Primary Liver Cancer).

Subjects
METABOLOMIC fingerprinting, LIVER cancer, DIAGNOSIS, TECHNOLOGICAL innovations
Abstract

Keywords: Nanjing; People's Republic of China; Asia; Biomarkers; Cancer; Cyborgs; Diagnostics and Screening; Emerging Technologies; Health and Medicine; Liver Cancer; Machine Learning; Oncology EN Nanjing People's Republic of China Asia Biomarkers Cancer Cyborgs Diagnostics and Screening Emerging Technologies Health and Medicine Liver Cancer Machine Learning Oncology 304 304 1 03/27/23 20230328 NES 230328 2023 MAR 28 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Researchers detail new data in Oncology - Liver Cancer. Herein, to high-coverage profile cis-diols and explore the translational potential of them as biomarkers, a machine learning-empowered boronate affinity extraction-solvent evaporation assisted enrichment-mass spectrometry (MLE-BESE-MS) was developed. [Extracted from the article]

Published
2023

30. New Metabolite Research Research from Federal University of Rio Grande Described (Application of 1H HR-MAS NMR-Based Metabolite Fingerprinting of Marine Microalgae).

Subjects
METABOLOMIC fingerprinting, MICROALGAE, MAGIC angle spinning, NUCLEAR magnetic resonance, MARINE natural products
Abstract

Diagnostics and Screening, Health and Medicine, Life Sciences, Metabolite Research, Nuclear Magnetic Resonance Keywords: Diagnostics and Screening; Health and Medicine; Life Sciences; Metabolite Research; Nuclear Magnetic Resonance EN Diagnostics and Screening Health and Medicine Life Sciences Metabolite Research Nuclear Magnetic Resonance 3492 3492 1 03/23/23 20230317 NES 230317 2023 MAR 17 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- A new study on metabolite research is now available. [Extracted from the article]

Published
2023

33. University of Siena Researchers Illuminate Research in Heart Failure (Laboratory and Metabolomic Fingerprint in Heart Failure with Preserved Ejection Fraction: From Clinical Classification to Biomarker Signature).

Subjects
METABOLOMIC fingerprinting, VENTRICULAR ejection fraction, CARDIAC research, BIOMARKERS, HEART failure, HEART diseases
Abstract

Keywords for this news article include: University of Siena, Siena, Italy, Europe, Biomarkers, Cardiology, Heart Disease, Heart Failure, Health and Medicine, Risk and Prevention, Diagnostics and Screening, Heart Disorders and Diseases, Cardiovascular Diseases and Conditions. Keywords: Biomarkers; Cardiology; Cardiovascular Diseases and Conditions; Diagnostics and Screening; Health and Medicine; Heart Disease; Heart Disorders and Diseases; Heart Failure; Risk and Prevention EN Biomarkers Cardiology Cardiovascular Diseases and Conditions Diagnostics and Screening Health and Medicine Heart Disease Heart Disorders and Diseases Heart Failure Risk and Prevention 2023 FEB 6 (NewsRx) -- By a News Reporter-Staff News Editor at Cardiovascular Week -- Investigators discuss new findings in heart failure. Biomarkers, Cardiology, Cardiovascular Diseases and Conditions, Diagnostics and Screening, Health and Medicine, Heart Disease, Heart Disorders and Diseases, Heart Failure, Risk and Prevention. [Extracted from the article]

Published
2023

Catalog

Books, media, physical & digital resources
See catalog results